» Articles » PMID: 28759461

Lasers for Pelvic Floor Dysfunctions: is There Evidence?

Overview
Date 2017 Aug 1
PMID 28759461
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: The purpose of this review is to discuss the available energy sources used in the vaginal canal that are currently being promoted for certain pelvic floor conditions and explore the body of peer-reviewed literature supporting their use.

Recent Findings: The majority of research has focused on the use of fractional CO2 laser treatment for genitourinary syndrome of menopause (GSM). Most of these studies are nonrandomized prospective studies, but their data consistently shows an improvement in symptoms without significant side effects.

Summary: Vaginal laser treatment for GSM is of particular interest to gynecologists as it provides patients with a history of estrogen receptor positive breast cancer, thromboembolic event, or other contraindication to hormone therapy, an effective treatment option. Currently, we are in the early stages of scientific investigation into the use of lasers in the treatment of pelvic floor dysfunction, but the emerging data is encouraging. The existing data is limited to mostly observational studies with additional quality randomized controlled trials and sham studies needed to ensure that physicians are providing the optimum evidence-based treatments to their patients. At the present time there is insufficient data to promote these therapies for stress incontinence, vaginal tightening, or other pelvic floor abnormalities.

Citing Articles

Regenerative Medicine in Urogynecology: Where We Are and Where We Want to Be.

Henderson T, Christman K, Alperin M Urogynecology (Phila). 2024; 30(5):519-527.

PMID: 38683203 PMC: 11342648. DOI: 10.1097/SPV.0000000000001461.


The efficacy of erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of decreased sexual sensation: a randomized, placebo-controlled trial.

Sathaworawong A, Manuskiatti W, Phatihattakorn C, Ungaksornpairote C, Ng J Lasers Med Sci. 2021; 37(1):581-588.

PMID: 33791888 DOI: 10.1007/s10103-021-03305-1.


The Rationale for Photobiomodulation Therapy of Vaginal Tissue for Treatment of Genitourinary Syndrome of Menopause: An Analysis of Its Mechanism of Action, and Current Clinical Outcomes.

Lanzafame R, de la Torre S, Leibaschoff G Photobiomodul Photomed Laser Surg. 2019; 37(7):395-407.

PMID: 31210575 PMC: 6648197. DOI: 10.1089/photob.2019.4618.


Genitourinary syndrome of menopause - is the problem solved? State of the art 2018.

Szymanski J, Zareba K, Jakiel G, Slabuszewska-Jozwiak A Prz Menopauzalny. 2019; 17(4):168-174.

PMID: 30766464 PMC: 6372854. DOI: 10.5114/pm.2018.81741.


IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.

Shobeiri S, Kerkhof M, Minassian V, Bazi T Int Urogynecol J. 2018; 30(3):371-376.

PMID: 30523374 DOI: 10.1007/s00192-018-3830-0.